InvestorsHub Logo
Followers 21
Posts 1400
Boards Moderated 0
Alias Born 03/03/2021

Re: HyGro post# 521997

Saturday, 10/15/2022 12:47:07 AM

Saturday, October 15, 2022 12:47:07 AM

Post# of 688715
US is dominant market because of very high prices, so, the numbers are skewed a bit. Your a numbers guy, you know that.

Nonocure does have 'device' approved. Revenue, yes. Hence, able to fund more trials. NWBO will take the same route when they have the impending approval and revenue generation over the coming years.

The TTF trials will be interesting to see if they hurt healthy cells division.

ASM= Actively Supporting Management

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News